Nimbus Synergies Co-Leads $2.26 Million Investment in Arbutus Medical to Accelerate Market Adoption of Skeletal Traction Innovation

Nimbus Synergies is pleased to announce the completion of a $2.26 million follow-on investment in portfolio company Arbutus Medical. This investment was led by Nimbus Synergies and Genome BC’s Industry Innovation (I²) Fund to support the commercialization of Arbutus Medical’s TrakPak® – a complete single-use procedure kit that contains everything a surgeon needs for skeletal traction.